Nexthera Capital as of June 30, 2017
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 39 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kite Pharma | 9.5 | $22M | 210k | 103.67 | |
| Shire | 7.3 | $17M | 102k | 165.27 | |
| AstraZeneca (AZN) | 7.3 | $17M | 490k | 34.09 | |
| Alexion Pharmaceuticals | 6.4 | $15M | 120k | 121.67 | |
| GlaxoSmithKline | 6.0 | $14M | 322k | 43.12 | |
| Celgene Corporation | 5.6 | $13M | 99k | 129.87 | |
| Pfizer (PFE) | 5.1 | $12M | 350k | 33.59 | |
| Neuroderm Ltd F | 4.3 | $9.8M | 327k | 29.90 | |
| Global Blood Therapeutics In | 4.0 | $9.3M | 340k | 27.35 | |
| Aclaris Therapeutics (ACRS) | 4.0 | $9.2M | 340k | 27.12 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $9.2M | 101k | 90.82 | |
| Impax Laboratories | 3.9 | $9.0M | 560k | 16.10 | |
| Alnylam Pharmaceuticals (ALNY) | 3.6 | $8.4M | 105k | 79.76 | |
| Tesaro | 3.6 | $8.3M | 59k | 139.89 | |
| Vanda Pharmaceuticals (VNDA) | 3.3 | $7.5M | 462k | 16.30 | |
| Array BioPharma | 2.9 | $6.7M | 800k | 8.37 | |
| Minerva Neurosciences | 2.2 | $5.1M | 575k | 8.85 | |
| Flexion Therapeutics | 2.0 | $4.7M | 231k | 20.22 | |
| Dova Pharmaceuticals | 1.9 | $4.4M | 198k | 22.29 | |
| Dermira | 1.5 | $3.5M | 121k | 29.14 | |
| Insmed (INSM) | 1.2 | $2.7M | 160k | 17.16 | |
| Ignyta | 1.1 | $2.6M | 250k | 10.35 | |
| Steadymed | 1.0 | $2.3M | 361k | 6.30 | |
| Abeona Therapeutics | 1.0 | $2.3M | 354k | 6.40 | |
| Cara Therapeutics (CARA) | 1.0 | $2.2M | 146k | 15.39 | |
| Ra Pharmaceuticals | 0.8 | $1.9M | 102k | 18.74 | |
| Kamada Ord Ils1.00 (KMDA) | 0.8 | $1.8M | 301k | 6.00 | |
| Aduro Biotech | 0.8 | $1.8M | 155k | 11.40 | |
| Advaxis | 0.7 | $1.6M | 252k | 6.49 | |
| Aquinox Pharmaceuticals | 0.6 | $1.3M | 91k | 14.07 | |
| Aileron Therapeutics | 0.6 | $1.3M | 114k | 11.15 | |
| Paratek Pharmaceuticals | 0.5 | $1.2M | 50k | 24.10 | |
| Marinus Pharmaceuticals | 0.3 | $685k | 500k | 1.37 | |
| Zosano Pharma | 0.3 | $590k | 418k | 1.41 | |
| Strongbridge Bioph shs usd | 0.2 | $477k | 67k | 7.15 | |
| Sierra Oncology | 0.2 | $468k | 400k | 1.17 | |
| Ovid Therapeutics (OVID) | 0.1 | $320k | 31k | 10.48 | |
| Obseva Sa | 0.1 | $299k | 35k | 8.54 | |
| Vistagen Therapeutics | 0.1 | $258k | 138k | 1.87 |
